Epigenomics Market to Witness Remarkable Expansion with Advancements in Epigenetic Research – By PMI
November 07, 2023 12:30 ET
|
PMI
Covina, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Epigenomics is the study of epigenetic modifications that influence gene expression without altering the underlying DNA sequence. These modifications can...
Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign
November 01, 2023 07:00 ET
|
Jonathan Milner
Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign CAMBRIDGE, England, 1 November 2023 - Jonathan Milner, the founder and one of the largest investors in Abcam plc...
Jonathan Milner Issues Statement Responding to the Glass Lewis Report
October 23, 2023 02:00 ET
|
Jonathan Milner
Jonathan Milner Issues Statement Responding to the Glass Lewis Report Welcomes the Glass Lewis report's observations on the disproportionate rewards for Abcam’s Executive Directors and on the...
Dr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace Board
September 14, 2023 08:00 ET
|
Jonathan Milner
Dr. Jonathan Milner opposes Danaher's acquisition of Abcam and calls for EGM to replace Board CAMBRIDGE, England, 14 September 2023 – Dr. Jonathan Milner, the founder and one of the largest investors...
Moore Kuehn Encourages RPT, ABCM, THRN, and HT Investors to Contact Law Firm
September 06, 2023 10:56 ET
|
Moore Kuehn
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
Jonathan Milner issues Open Letter to shareholders of Abcam plc
June 23, 2023 07:00 ET
|
Jonathan Milner
Jonathan Milner issues Open Letter to shareholders of Abcam plc Highlights Abcam Board’s track record of failing to pursue strategic M&A opportunities and lack of incentive to drive share...
Jonathan Milner issues Open Letter to shareholders of Abcam plc
June 12, 2023 07:00 ET
|
Jonathan Milner
Jonathan Milner issues Open Letter to shareholders of Abcam plc Highlights Company’s loss of focus on governance, execution and cost control leading to value destruction and a share price materially...